Agilent adds ex-Stryker CFO to board, names new chair

Agilent Technologies, Inc. (A) reported governance changes to its board of directors.

Rhea-AI Filing Summary

Agilent Technologies, Inc. (A) reported governance changes to its board of directors. On September 2, 2026, longtime director and board chair Boon Hwee Koh notified the company of his decision to retire from the board, effective September 4, 2026, after roughly 23 years of service; the company states his decision was not due to any disagreement regarding operations, policies, or practices.

Effective September 4, 2026, the board appointed Glenn Boehnlein, age 64 and former Vice President and Chief Financial Officer of Stryker Corporation, as a Class III director, and named him to the Audit and Finance Committee and the Compensation Committee. The board determined that he is independent under New York Stock Exchange corporate governance standards and that he qualifies as an “audit committee financial expert.” Separately, the board elected Dow R. Wilson, a director since 2018, to serve as board chair.

Agilent describes Boehnlein’s background in senior finance roles at Stryker, prior CFO and audit experience, and current board roles at Inogen Inc. and Sutter Health. He will receive the company’s standard non-employee director compensation and enter into Agilent’s standard indemnification agreement. Agilent also notes that it generated $6.95 billion in revenue in fiscal 2025 and employs about 18,000 people worldwide.

8-K Event Classification

3 items: 5.02, 7.01, 9.01

3 items

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers Governance

Key personnel changes including departures, elections, or appointments of directors and executive officers.

Item 7.01 Regulation FD Disclosure Disclosure

Material non-public information disclosed under Regulation Fair Disclosure, often investor presentations or guidance.

Item 9.01 Financial Statements and Exhibits Exhibits

Financial statements, pro forma financial information, or exhibit attachments filed with this report.

Key Figures

Board chair retirement effective date: September 4, 2026 New director appointment date: September 4, 2026 Glenn Boehnlein age: 64 years +4 more

7 metrics

Board chair retirement effective date September 4, 2026 Effective date of Boon Hwee Koh’s retirement from Agilent’s board

New director appointment date September 4, 2026 Effective date of Glenn Boehnlein’s appointment as Class III director

Glenn Boehnlein age 64 years Age of newly appointed Agilent director

Fiscal 2025 revenue $6.95 billion Agilent revenue in fiscal year 2025

Number of employees 18,000 employees Approximate global workforce as stated by Agilent

Years at Stryker Corporation 22 years Tenure of Glenn Boehnlein at Stryker Corporation

Service as Stryker CFO 2016–2025 Period when Glenn Boehnlein served as Vice President and CFO of Stryker

Key Terms

independent chair, audit committee financial expert, Regulation FD Disclosure, corporate governance listing standards, +1 more

5 terms

independent chair regulatory

"Koh Boon Hwee, independent chair of the company's board of directors"

audit committee financial expert regulatory

"meets the definition of "audit committee financial expert" as set forth"

A person on a company’s board who has deep knowledge of accounting, financial reporting and auditing, able to understand and question the books, controls and audit work like a trained mechanic inspecting an engine. Investors care because that expertise helps spot errors, weaknesses or misleading statements early, improving the likelihood that financial reports are accurate and reducing the risk of surprises that can hurt a company’s value.

Regulation FD Disclosure regulatory

"Item 7.01 - Regulation FD Disclosure. The Company issued a press release"

Regulation FD disclosure requires public companies to share important, market-moving information with everyone at the same time instead of tipping off analysts or large investors first. Think of it as making sure all players on a field hear the same announcement simultaneously; that fairness helps investors trust that stock prices reflect the same information and reduces the risk of sudden, unfair trading advantages or regulatory penalties for selective leaks.

corporate governance listing standards regulatory

"in compliance with the New York Stock Exchange corporate governance listing standards"

indemnification agreement regulatory

"will enter into a standard indemnification agreement with the Company"

An indemnification agreement is a contract in which one party promises to cover losses, costs, or legal claims that another party might face, acting like a tailored safety net or private insurance policy. For investors, it matters because such agreements shift potential financial risk away from a company or its officers and onto the indemnifier, which can affect a company’s future liabilities, cash flow and how risky the investment appears during deal-making or litigation.

FAQ

What board changes did Agilent Technologies (A) announce in this 8-K?

Agilent announced that Boon Hwee Koh retired from the board effective September 4, 2026, that Glenn Boehnlein joined the board as a Class III director, and that Dow R. Wilson was elected board chair, all effective on the same date.

Why did Agilent’s board chair Boon Hwee Koh retire from the board?

Agilent states that Boon Hwee Koh decided to retire from the board effective September 4, 2026 and that his decision was not due to any disagreement with the company or the board regarding its operations, policies, or practices.

Who is Glenn Boehnlein, the new Agilent (A) board member, and what is his background?

Glenn Boehnlein, age 64, spent 22 years at Stryker Corporation, serving as Vice President and Chief Financial Officer from 2016 to 2025. He previously held senior finance roles, was CFO of MyPrimeTime, and a partner and CPA at Arthur Andersen LLP.

Is Glenn Boehnlein considered independent and financially qualified under SEC and NYSE rules?

Agilent’s board determined that Glenn Boehnlein meets the independence standards adopted in compliance with New York Stock Exchange corporate governance listing standards and Item 407(a) of Regulation S-K, and that he qualifies as an “audit committee financial expert” under Item 407(d)(5)(ii).

Which board committees will Glenn Boehnlein serve on at Agilent Technologies (A)?

Effective September 4, 2026, Glenn Boehnlein will serve on Agilent’s Audit and Finance Committee and the Compensation Committee, in addition to his role as a Class III director.

What recent financial scale did Agilent (A) disclose in this document?

Agilent states that it generated $6.95 billion in revenue in fiscal year 2025 and employs approximately 18,000 people worldwide, highlighting the company’s scale as a global provider of analytical and clinical laboratory technologies.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/08/2026 - 08:16 AM Accepted by SEC EDGAR 09/08/2026 - 08:15 AM Learn about SEC filing dates

0001090872false00010908722026-09-022026-09-02

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): September 02, 2026

AGILENT TECHNOLOGIES, INC.

(Exact name of Registrant as Specified in Its Charter)

Delaware			001-15405	77-0518772
(State or Other Jurisdiction of Incorporation)			(Commission File Number)	(IRS Employer Identification No.)
5301 Stevens Creek Boulevard
Santa Clara, California				95051
(Address of Principal Executive Offices)				(Zip Code)

Registrant’s Telephone Number, Including Area Code: 800 227-9770

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common Stock, $0.01 par value		A		New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) On September 2, 2026, Boon Hwee Koh, Chairperson of the Board of Directors (the "Board") of Agilent Technologies, Inc. (the "Company"), notified the Company of his decision to retire from the Board, effective as of September 4, 2026. Mr. Koh's decision to retire was not due to any disagreement with the Company or the Board on any matter relating to the Company's operations, policies or practices. The Company and the Board thank Mr. Koh for his valuable insights, perspective, and commitment during his 23-year service on the Board.

(d) On September 4, 2026, the Board upon the recommendation of its Nominating/Corporate Governance Committee, appointed Glenn Boehnlein, to fill the vacancy created by the resignation of Mr. Koh, effective September 4, 2026 to serve as a Class III director, the class of directors that will stand for re-election at the 2027 Annual Meeting of Stockholders.

The Board has determined that Mr. Boehnlein meets the independence standards adopted by the Company in compliance with the New York Stock Exchange corporate governance listing standards and Item 407(a) of Regulation S-K, and that Mr. Boehnlein meets the definition of "audit committee financial expert" as set forth in Item 407(d)(5)(ii) of Regulation S-K. The Board has also appointed Mr. Boehnlein to the Board's Audit and Finance Committee and the Board's Compensation Committee, effective as of September 4, 2026.

Mr. Boehnlein, age 64, served as Vice President and Chief Financial Officer of Stryker Corporation from 2016 to 2025. During his more than two decades at Stryker, he held several senior finance leadership roles, including Chief Financial Officer and Vice President of the company’s MedSurg and Neurotechnology Group and Chief Financial Officer of its Global Endoscopy Division. Earlier in his career, Mr. Boehnlein served as Chief Financial Officer of MyPrimeTime, a media company, and as a partner at Arthur Andersen LLP, where he provided audit and consulting services to clients across the technology sector. Mr. Boehnlein serves on the Board of Directors of Inogen, Inc., a publicly traded medical technology company focused on respiratory health solutions, where he chairs the Audit Committee. He also serves on the board of Sutter Health, one of the nation’s leading integrated healthcare systems. Mr. Boehnlein earned bachelor’s and master’s degrees in professional accountancy from Mississippi State University.

Mr. Boehnlein has (i) no arrangements or understandings with any other person pursuant to which he was appointed as a director, and (ii) no family relationship with any director or executive officer of the Company or any person nominated or chosen by the Company to become a director or executive officer.

Mr. Boehnlein has had no direct or indirect material interest in any transaction or series of similar transactions contemplated by Item 404(a) of Regulation S-K.

Mr. Boehnlein will receive the standard compensation, a portion of which will be pro-rated to reflect the actual time Mr. Boehnlein will serve on the Company’s Board this year, paid by the Company to all of its non-employee directors and as described under “Compensation of Non-Employee Directors” in the Company’s Proxy Statement for its Annual Meeting of Stockholders filed with the Securities and Exchange Commission (“SEC”) on February 6, 2026. In connection with his appointment, Mr. Boehnlein will enter into a standard indemnification agreement with the Company in the form previously approved by the Board, which is filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed with the SEC on April 10, 2008 and is incorporated by reference herein.

Item 7.01 - Regulation FD Disclosure.

The Company issued a press release on September 8, 2026 announcing the retirement of Mr. Koh and appointment of Mr. Boehnlein to the Company’s Board. A copy of the press release is furnished as Exhibit 99.1 to this report.

The information in this Item 7.01 and Exhibit 99.1, attached hereto, are intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 - Financial Statements and Exhibits.

(d) Exhibits

Exhibit No.		Description
99.1		Press release, dated September 8, 2026, announcing board chair resignation and new board member appointment.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			AGILENT TECHNOLOGIES, INC.
Date:	September 8, 2026	By:	/s/ Michael Buckner
		Name:	Michael Buckner
		Title:	Senior Vice President, Chief Legal Officer and Secretary

Exhibit 99.1

Agilent Announces Retirement of Board Chair Koh Boon Hwee, Appointment of Glenn Boehnlein to Board of Directors

SANTA CLARA, Calif., Sept. 8, 2026 — Agilent Technologies Inc. (NYSE: A) today announced that Koh Boon Hwee, independent chair of the company's board of directors, retired from the board effective Sept. 4, 2026, following more than two decades of service as a director. Koh joined Agilent’s board in 2003 and served as independent chair from 2017 until his retirement.

He chaired the board’s Executive Committee and Nominating and Corporate Governance Committee. Koh brought extensive international leadership and public-company governance experience to the board, including deep expertise in the Asia-Pacific region.

Following Koh's retirement, the board of directors elected Dow R. Wilson to serve as chair, effective Sept. 4, 2026. Wilson has served on Agilent's board of directors since 2018 and currently chairs the Audit and Finance Committee. The board believes his leadership experience, governance expertise and knowledge of the company will support a seamless transition and continued strong oversight of Agilent's long-term strategy.

“On behalf of the board and Agilent, I want to thank Boon Hwee for his exceptional leadership, counsel and commitment to the company over more than two decades of service,” said Padraig McDonnell, president and CEO of Agilent. “His steady judgment, global perspective and appreciation for both Agilent’s heritage and its potential have helped guide the company through important strategic decisions and leadership transitions. On a personal level, I am deeply grateful for the support and perspective he provided as I transitioned into the CEO role. We wish him all the best in retirement.”

The company also announced the appointment of Glenn Boehnlein to its board of directors, effective Sept. 4, 2026. Boehnlein spent 22 years at Stryker Corporation, serving as vice president and chief financial officer from 2016 until his retirement from the role in 2025. Earlier in his Stryker career, he held senior finance leadership positions in the company’s MedSurg and Neurotechnology Group and Endoscopy Division. As CFO, he led Stryker’s global finance function, with his responsibilities expanding in 2020 to include information technology. Boehnlein previously served as chief financial officer of MyPrimeTime and as a partner and certified public accountant at Arthur Andersen LLP. He currently serves on the boards of directors of Inogen Inc. and Sutter Health and holds bachelor’s and master’s degrees in accountancy from Mississippi State University.

“Glenn’s extensive financial leadership experience, deep knowledge of the medical technology sector and public-company board experience will further strengthen the range of expertise represented on our board,” McDonnell added. “We look forward to the insights he will bring as Agilent continues to execute its strategy and create long-term value for shareholders.”

“I am honored to join Agilent’s board of directors,” said Boehnlein. “Agilent has a strong reputation for innovation, operational excellence and customer focus. I look forward to working with the board and management team to support the company's strategy and long-term success.”

# # #

About Agilent Technologies

Agilent Technologies, Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments,

Exhibit 99.1

software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.

INVESTOR CONTACT:

Tejas Savant

+1 917-574-4018

tejas.savant@agilent.com

MEDIA CONTACT:

Andréa Topper +1 408-709-0060 andrea.topper@agilent.com

Filing Exhibits & Attachments

2 documents

Press Releases

• EX-99.1 EX-99.1 17.1 KB

Other Documents

• EX-101 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT 23.3 KB